VERONA PHARMA PLC - ADR (VRNA)
US9250501064 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 271.77M | 227.80M | 148.40M | 188.00M | 30.40M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 10.40M | |||
| Receivables | 10.95M | 9.30M | 15.60M | 8.30M | 9.80M | |||
| Other Current Assets | 6.98M | 5.90M | 6.10M | 6.20M | 3.70M | |||
| Total Current Assets | 289.71M | 243.00M | 170.10M | 202.50M | 54.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.87M | 900.00K | 1.00M | 1.20M | 1.40M | |||
| Investments And Advances | 15.00M | 15.00M | 15.00M | N/A | N/A | |||
| Goodwill | 545.00K | 500.00K | 500.00K | 500.00K | 600.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 18.42M | 16.50M | 16.50M | 1.70M | 1.90M | |||
| TOTAL ASSETS | 308.12M | 259.50M | 186.60M | 204.20M | 56.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 4.76M | 14.40M | 22.90M | 11.70M | 9.60M | |||
| Accounts Payable | 3.49M | 2.90M | 10.00M | 200.00K | 1.90M | |||
| Other Current Liabilities | 435.00K | 1.70M | 500.00K | 2.40M | 1.30M | |||
| Total Current Liabilities | 8.69M | 19.00M | 33.40M | 14.20M | 12.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 48.37M | 9.80M | 4.90M | 4.60M | 0.00 | |||
| Other Non-Current Liabilities | 1.77M | 200.00K | 300.00K | 500.00K | 700.00K | |||
| Total Non-Current Liabilities | 50.15M | 10.00M | 5.20M | 5.20M | 700.00K | |||
| TOTAL LIABILITIES | 58.84M | 29.00M | 38.60M | 19.40M | 13.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -388.43M | -333.10M | -263.70M | -207.10M | -141.80M | |||
| Additional Paid In Capital | 601.06M | 529.20M | 385.10M | 366.40M | 179.50M | |||
| Common Shares | 42.77M | 40.50M | 31.90M | 31.80M | 7.30M | |||
| Treasury Stock | -1.52M | -1.50M | -600.00K | -1.70M | 0.00 | |||
| Other Shareholders' Equity | -4.60M | -4.60M | -4.60M | -4.60M | -2.30M | |||
| Shares Outstanding | 77.60M | 73.11M | 57.90M | 55.87M | 12.70M | |||
| Tangible Book Value per Share | 0.39 | 0.38 | 0.31 | 0.40 | 0.40 | |||
| Total Shareholders' Equity | 249.28M | 230.50M | 148.00M | 184.90M | 42.70M | |||
| TOTAL LIABILITIES AND EQUITY | 308.12M | 259.50M | 186.60M | 204.20M | 56.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.19 | 0.04 | 0.03 | 0.02 | N/A | |||
| Current Ratio | 33.33 | 12.79 | 5.09 | 14.26 | 4.24 | |||
| Return On Assets (ROA) | -17.65% | -26.47% | -29.78% | -31.90% | -72.17% | |||
| Return On Equity (ROE) | -21.81% | -29.80% | -37.55% | -35.24% | -94.99% | |||
All data in USD